This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mullaney, D T
Right arrow Articles by John, J F
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mullaney, D T
Right arrow Articles by John, J F, Jr

 Previous Article  |  Next Article 

Antimicrob Agents Chemother. 1982 March; 21(3): 421-425

Cefotaxime therapy of serious bacterial infection in adults.

D T Mullaney and J F John Jr

ABSTRACT

We evaluated the efficacy, safety, and tolerance of cefotaxime in 35 adults (25 with pleuropulmonary infections, 7 with genitourinary tract infections, and 3 with soft tissue infections). Of these 35 patients, 18 (51.4%) were seriously or critically ill. In vitro susceptibility testing revealed that 90.4% of the pathogens isolated were susceptible to cefotaxime (minimal inhibitory concentration, less than 8 micrograms/ml), 4.8% were intermediately susceptible (minimal inhibitory concentration, 8 to 32 micrograms/ml), and 4.8% were resistant (minimal inhibitory concentration, greater than 32 micrograms/ml). A total of 34 of the 35 patients (97%) were clinically and bacteriologically cured of their infections. Adverse reactions occurred in two patients, but these reactions did not require interruption of therapy.


Antimicrob Agents Chemother. 1982 March; 21(3): 421-425




This article has been cited by other articles:

  • Mullaney, D. T., John, J. F. (1983). Cefotaxime Therapy: Evaluation of Its Effect on Bacterial Meningitis, CSF Drug Levels, and Bactericidal Activity. Arch Intern Med 143: 1705-1708 [Abstract]